Nitinol Staple, Elastic Staple Small-Asymmetrical, Sterile R, Model #: a) ES-10x13x15; b) ES-10x1...
FDA Device Recall #Z-2264-2018 — Class II — April 13, 2018
Recall Summary
| Recall Number | Z-2264-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 13, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | TriMed Inc. |
| Location | Santa Clarita, CA |
| Product Type | Devices |
| Quantity | 706 |
Product Description
Nitinol Staple, Elastic Staple Small-Asymmetrical, Sterile R, Model #: a) ES-10x13x15; b) ES-10x16x19; c) ES-10x17x19; d) ES-12x13x15; e) ES-12x15x17; f) ES-12x16x19; g) ES-15x13x16
Reason for Recall
During a retrospective review of sterilization records, TriMed has determined that evidence of quarterly dose audits/verification required to comply with the regulations could not be found. Sterilization records indicate that all lots of staples were irradiated to at least the defined dose. There is a risk that this issue could result in patient infection if not properly sterilized.
Distribution Pattern
U.S.: IL, UT, PA, NJ, WA, TX, NV, CA, NC, MS, KS, MO, MN, FL; OUS: Australia and Sweden
Lot / Code Information
Lot #: a) 00A5, 26406, R889, 03UJ, 003UJ, 050514, 10505-14, 264-06, 004P, 26404, 10505-14, 226001, 264, 26401, 22600; b) 004S; c) 004R; d) 050518, 10505-18, 021G, 021F, 0505018, 11788, 080818, 178801, 17881, 316801; e) R895, 050519, 10505-19, 2012BJ, 004V, 009D, 0505019, 178901, 180502, 17890, 1178901, 00AB, 0090, 0091, 78901; f) 009E, 11264, R896, 004W, 183701, 11837, 050520, 10505-20, 178901, 10505-20, 083701, 118337, 08370, 26407, 264-07; g) 03UR, 26408, 264-08, 050521, 26406, 264-06, 1050521, 179001, 10505-21, 179002
Other Recalls from TriMed Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1791-2024 | Class II | TriMed, Threaded IM Nail 3.6mm, 60mm, TI, Ref: ... | Mar 19, 2024 |
| Z-1792-2024 | Class II | TriMed, Threaded IM Nail 3.6mm, 60mm, TI, Ref: ... | Mar 19, 2024 |
| Z-0932-2024 | Class II | Volar Bearing Plate. REF: VBEAL-3-7N, VBEAL... | Nov 28, 2023 |
| Z-1101-2023 | Class II | RipCord Syndesmosis Button, REF: STA001K | Dec 22, 2022 |
| Z-0359-2020 | Class II | TriMed Wrist Hook Dorsal Impactor, REF IMPCT-WH... | Sep 28, 2018 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.